Thus, NFATc1 promotes CRC tumorigenesis by concurrently activating the NADK and MDM2 pathways, which together disrupt essential cellular processes—including metabolic enzyme activity, NAD+/NADP+ redox homeostasis, and cell cycle control. This evidence concerns the gene NADK and colorectal carcinoma.